Guided Therapeutics Inc (GTHP)

[myjog]

Even if claims are not against GTHP, still a CEO & 1 of the directors are being sued, should the company not have disclosed this to stockholders in either 10-Q or 10-K or any other PR?
If you think that you didn’t do anything wrong then why don’t hide such a thing from stockholders?
Also, if you have nothing to hide then why company’s management don’t have any social media presence? None of the company’s management have any social media presence in either Facebook or LinkedIn or Twitter (now X) or Instagram. Why?
As far as stock price is concerned, it’s extremely sad state of affairs. There are no buyers. There are only sellers & sellers are such that they are willing to sell at any bid price they can get. As if they just want to get out of their long positions for any salvage price they can get. Desperate to dump their stock at any price,

[Pacjd]

I know what Gene is, I have dealt with him and I am glad that he is gone.

I disagree with you but will keep my personal opinions of Gene to myself.

In speculation, however, maybe Gene's Resignation was based on his wanting to cut off ties with Faupel and Blumberg - only Gene could answer to that and I would not necessarily accept Gene's answer.

[GetSeriousOK]

True words.

I was sorry to see Cartwright go. If the summary judgement was the reason... Good for Cartwright, bad for GTI.

If Cartwright comes out of retirement to captain another biotech, I would invest, because I believe that what he did at GTI was nothing short of a miracle. He's on the Board at Nanosphere in Illinois.... maybe he'll take the helm. Not a publicly traded company but I'm an accredited investor.

[myjog]

If you look at today’s trading then you will see that there are net sales. There are no buyers for this stock.

[Pacjd]

GIUL, LLC 9-19-2023 Press Release:

SEE POST BELOW From: GetSerious 10/05/23 5:52 PM

[Pacjd]

The law Suit by GIUL, LLC is against Mark L. Faupel, and attorney Blumberg , both individually, for Massachusetts securities violations among other things in connection with funds GIUL first provided to a company called Shenghuo Medical, LLC, which funds were lent to GTI.

GUIL, LLC, as Plaintiff, is also bring claims against Mr. Faupel and attorney Blumberg in connection with such fund raising activities for violations of the Massachusetts unfair and deceptive trade practices statute, and conspiracy.

GTI GTHP itself is not a party to the case and so there are no claims in the case against GTI.

[myjog]

Not only you but there are many other investors who are bearish on the stock. This news about a lawsuit on CEO & 1 of the directors, is that information disclosed to stockholders in any 10-Q or 10-K or any other PR?

[Pacjd]

Very interesting that Gene Cartwright, CEO GTHP, Resignation - came very shortly after the Massachusetts Superior Court Judge issued this summary judgement decision that the Plaintiff- GIUL, LLC, (which is managed by a retired attorney) could continue to proceed suing Mark L. Faupel, now President and Chief Executive Officer of GTI, as well as Richard P. Blumberg, Esq., an attorney from the Seattle, Washington area, Blumberg now a Director of GTI.

[GetSeriousOK]

he's basically filing a complaint against the top two brokers who trade GTHP.

If you look at the L2 quotes on the OTCBB site you'll see that GTSM is pretty much the top broker on both the BID and ASK sides of the equation, as is true for almost every OTCQB ticker.

https://www.otcmarkets.com/stock/GTHP/quote

In summary: I think he's tilting at windmills. But everyone needs a hobby.

I don't see CFGN on the other OTCQB tickers I watch, but here's their website -- they don't strike me as the kind of entity that would manipulate stocks, but what do I know.

https://celadonfinancial.com/

I'm intrigued by the Shenghuo / GIUL drama. The "Contact" for the Sept. 2023 PR (I'm not going to post his name, but look at the end) is the plaintiff (the owner of GIUL). I haven't looked up his original complaint yet but I will try to find it. At the core is a $64,000 loan.

[GetSeriousOK]

Here is the "Shenghuo defense" from Feb 2023. Interesting reading!

https://bostonbusinesslaw.com/wp-content/uploads/2023/02/Giul-LLC-v.-Shenghuo-Medical-LLC.pdf

[GetSeriousOK]

Faupel and Blumberg have some 'splainin' to do!

https://www.law.com/legalnewswire/post-detail/judge-denies-motion-to-end-some-claims-against-persons-who-are-the-ceo-and-a-director-of-guided-therapeutics/

A judge of the Massachusetts Superior Court has now denied the efforts of the President/Chief Executive Officer, as well as a Director, of Guided Therapeutics Inc. (“GTI”) to prevent trial on individual civil claims against them in connection with fundraising, first provided to another company with which they were each connected, but which funds were ultimately lent to GTI. The claims are brought by a Massachusetts-based investor against them for violation of the Massachusetts state securities law, the Massachusetts unfair and deceptive trade practices statute, and conspiracy. GTI itself is not a party to the case and so there are no claims in the case against GTI.

The Massachusetts-based investor, GIUL, LLC, has sued Mark L. Faupel, now President and Chief Executive Officer of GTI, as well as Richard P. Blumberg, Esq., an attorney from the Seattle, Washington area, Blumberg now a Director of GTI, for securities violations among other things in connection with funds GIUL first provided to a company called Shenghuo Medical, LLC, which funds were lent to GTI. Mr. Blumberg, Esq., was a managing member of Shenghuo Medical at the time while Mr. Faupel was a consultant. Another managing member of Shenghuo Medical was also sued along with Shenghuo’s corporate attorney. The court concluded that there was evidence presented to date plausibly establishing that both Mr. Faupel and Mr. Blumberg, Esq., were involved in this fundraising. The court further concluded that there was evidence presented to date plausibly proving that both Mr. Faupel and Mr. Blumberg, Esq., in connection with this fundraising, engaged in conduct that violated Massachusetts securities laws, Massachusetts law barring unfair and deceptive trade practices, and Massachusetts law against conspiracy. The suit does not allege that they engaged in this conduct as officers and directors of GTI. But the suit does allege that part of the benefit from their conduct accrued to GTI.

Messrs. Faupel and Blumberg, Esq., and the other defendants brought a motion for summary judgment to try and end GIUL’s claims against them without trial. A judge of the Massachusetts Superior Court has now ruled denying the motion for summary judgment as to the securities claim, the unfair and deceptive trade practice claim, and the conspiracy claim and permitted these three claims to go to trial. He did grant summary judgment as to claims for breach of contract, breach of fiduciary duty, reach and apply, and fraud. As a result, Mr. Faupel and Mr. Blumberg, Esq., along with the other defendants, could be found liable at trial for securities violations, unfair and deceptive trade practices, and conspiracy with respect to fundraising that was lent to GTI.

The Court has now scheduled the trial for March 2024.

For those new to GTHP, Shenghuo Medical was replaced in China by SMI (rather abruptly, I might add as conjecture).

[GetSeriousOK]

Don't forget to put me on Ignore for all of your aliases -- myjog, myjo, and whatever else you use.

Do you realize that I'm basically the only person who ever responds to any of your posts? If you put me on Ignore, this is going to be a lonely forum for you.

[GetSeriousOK]

tsk, tsk, temper, temper.

First you said the Directors and Officers were fake and didn't exist. then you said the CEO stole the money and would never start clinical trials. Yet you think YOU "add value to this forum."

I have never personally attacked you -- I only ask you to explain what you wrote, which you never do. I have never called you an idiot and I have never said your IQ is low. You, on the other hand, personally attack ME every time you respond to one of my posts. Think about it.

[myjog]

You are seriously unique idiot. I’ve seen idiots but you are truly unique.
I was never basher of the stock. I was basher of incompetence.
Be a man & start buying.
If you don’t have money to put where your filthy mouth is, then shut up.
Start buying if you think stock is going to go up.
You haven’t provided any value add to this forum & always personally attacked me.
Many times in the past I ignored you but it seems like for a low IQ person like you, it’s required for me to state explicitly that I’m ignoring you. Period.

[GetSeriousOK]

Put up all you have for 13 cents.

Since you DON'T think it has potential to go up, put your stock where YOUR mouth is.
Do you have any stock to put where your mouth is?
Oh wait
You are just empty word basher.
Be a man & start selling. Will you?

[myjog]

Unlike you, I’ve many more. How much you are willing to buy & what price?
My challenge is still open, if you think that this stock has potential to go up then where are your buys?
Put your money where your mouth is.
Do you have any money to put where your mouth is?
Oh wait
You are just empty word pumper.
Be a man & start buying. Will you?

[2themoon1]

According to my Bloomberg, Auctus had 365,800 shares prior to the last financing last September which were sold in January and beginning of February of this year....according to their last filing March 23, 2023. So it looks like all they have left is what they have from that last financing...all of which is underwater. That said, i agree that they are probably not likely to be a seller of GTHP in the face of a SEC investigation.

[GetSeriousOK]

Does myjo agree with you, myjog?

You're right of course. I don't know that it was Auctus dumping on June 8th. It might have been all those Directors and Officers you claim don't exist.

Or was it you dumping on June 8th? Got any more?

[Pacjd]

Birds of a Feather Flock Together!

I wonder who at GTHP got Auctus Fund Management to invest into GTHP?

Does anyone here know?

My speculative guess would be Richard Paul Blumberg, ESQ, Director GTHP, also ,Manager of Shenghou, LLC now know as "K2".

[myjog]

And how do you know that June 08th dump was from Auctus?
Also, if you are confident about the stock’s potentialthen how does it matter who’s dumping and who’s not?
My challenge is still open, if you think that this stock has a potential to go up, then where are your buys?

[GetSeriousOK]

Nobody wants to buy until they're confident that Auctus has finished dumping. That June 8th dump made everyone cautious.

[GetSeriousOK]

Auctus didn't register as a securities dealer.

It's dry reading, but I recommend reading the SEC complaint.

https://www.sec.gov/files/litigation/complaints/2023/comp25741.pdf

This is really interesting to discuss. This epitomizes the risks and hazards of OTC trading, IMO.

The SEC is specifically calling Auctus a "toxic lender." My definition of "toxic lender" is a lender that also shorts the stock, sending the borrower into a death spiral. GTHP suffered from that kind of toxic lender between 2014 and 2019, but the PPS held after that 2019 R/S and I don't think it would have held if Auctus was shorting.

[dannee]

Can you please explain briefly what's the violation here by Auctus? We all know they had "toxic" convertible debt which was restructured a few times. But what's illegal here? Convertible buying under market price is common within OTC penny stocks

[GetSeriousOK]

Auctus must still have shares acquired in 2021 or earlier:

https://www.otcmarkets.com/filing/html?id=15693208&guid=A15-kpLgC72fJih

search for "Auctus"

I think they might dump more stock, in other words. Again, Auctus is innocent until proven guilty, but the SEC case looks solid to me. If the SEC wins the case, any GTHP stock Auctus acquired in 2021 or earlier will most likely be surrendered.

The SEC ordered a jury trial. That will take some time.

June 8th was the big dump day, 651,700 volume, just a few days after the SEC action. That was obviously Auctus dumping. I wonder how many shares, if any, they have left that were acquired in 2021 or earlier that they feel they need to dump. They received 500,000 shares in June 2020.... they must have dumped those. The 3.9 million shares they received in Sept 2022 might be protected from the SEC.

[GetSeriousOK]

Auctus could start dumping. It was probably Auctus that dumped earlier this year, but that was nowhere near 3.9M shares, so they must still have a considerable pile of GTHP stock.

Auctus is "innocent until proven guilty," but if they thought their GTHP stock was obtained in 2021 or earlier and they thought the SEC had a good case against them....

[GetSeriousOK]

it's interesting reading:

https://www.sec.gov/files/litigation/complaints/2023/comp25741.pdf

In hindsight, it looks like Auctus was feeling the heat from the SEC when they restructured the GTHP debt in the Sept. 2022 "Exchange Agreement." That Agreement was extremely favorable to GTHP and it came in tandem with the abrupt cancellation of the S-1 which was extremely favorable to GTHP shareholders. It made no sense at the time, but it makes sense now if Auctus owners were feeling the hot breath of the SEC on the backs of their necks and were doing damage control.

Auctus got 3.9 million shares of stock as part of that Exchange Agreement, as we all knew would happen, and they still have about 8 million warrants at 50 cents and 65 cents and $224,000 in convertible debt as of June 2023.

The bolding emphasis in this excerpt from the 10-Q is mine:
https://www.otcmarkets.com/filing/html?id=16852276&guid=ik5-kqJFccRuB3h

9. CONVERTIBLE DEBT
Auctus Convertible Note

On December 17, 2019, the Company entered into a securities purchase agreement and convertible note with Auctus. The convertible note issued to Auctus was for a total of $2.4 million. The note may not have been prepaid in whole or in part except as otherwise explicitly allowed. Any amount of principal or interest on the note which was not paid when due shall bore interest at the rate of the lessor of 24% or the maximum permitted by law (the “default interest”). The variable conversion prices equaled the lesser of: (i) the lowest trading price on the issue date, and (ii) the variable conversion price. The variable conversion price was 95% multiplied by the market price (the market price means the average of the five lowest trading prices during the period beginning on the issue date and ending on the maturity date), minus $0.04 per share, provided however that in no event could the variable conversion price be less than $0.15. If an event of default under this note occurred and/or the note was not extinguished in its entirety prior to December 17, 2020, the $0.15 price floor no longer applied.

On September 1, 2022, the Company agreed to exchange certain debt and equity owned by Auctus pursuant to an Exchange Agreement between the Company and Auctus (the “Exchange Agreement”). Immediately prior to the Exchange Agreement, Auctus held $1,228,183 of debt, including an early prepayment penalty of $350,000, default premiums of $281,256, and $91,555 in interest payable. Auctus agreed to reduce the amount owed to $710,911 and to revert the May 27, 2020 note to its original term. Additionally, Auctus agreed to exchange 8,775,000 warrants that were priced between $0.15 and $0.20 and the $350,000 prepayment penalty for 3,900,000 shares of common stock, warrants to purchase 3,900,000 shares of common stock at $0.50 per share and warrants to purchase 3,900,000 shares of common stock at $0.65 per share (the “Exchange”). As a result of the Exchange Agreement, Auctus forgave a default penalty of $225,444. Following the Exchange and Repayment, the Company will make payments to Auctus in four installments, over an 18-month period.

The total balance of Auctus convertible debt outstanding was $224,528 and $326,016 as of June 30, 2023 and December 31, 2022, respectively. As of June 30, 2023, the balance is included within “Short-term convertible debt” on the unaudited condensed consolidated balance sheet. As of December 31, 2022, $230,482 is included within “Short-term convertible debt” and $95,534 is included within “Long-term convertible debt” on the condensed consolidated balance sheet.

Notice item 57.E. in the SEC action -- the SEC wants Auctus to "surrender and [cancel] any securities (including convertible notes, warrants, and shares) obtained by Auctus in connection with its convertible notes business between 2013 and 2021." Because Auctus restructured the GTHP debt in Sept 2022 I don't know if their current GTHP securities are included. I'd like others' opinions on this. I am thinking that Auctus covered their tracks on this because none of their current debt, stock, or warrants were obtained in 2021 or earlier.

[Pacjd]

Auctus management, investor in GTHP being sued by SEC.

U.S. SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 25741 / June 1, 2023

Securities and Exchange Commission v. Auctus Fund Management, LLC, Louis Posner, and Alfred Sollami, No. 1:23-cv-11233-AK (D. Mass. filed June 1, 2023)

SEC Charges Massachusetts-Based Firm and Its Co-Owners with Acting as Unregistered Securities Dealers

[myjog]

Are you buying any of this stock?
Where are your buys?
Do you have any money to put where your mouth is?
You don’t have any money. All you have is empty words.
My challenge is still open, if you think this stock has potential to go up, then start buying. If you don’t buy then just shut up. Your empty words don’t add any value to this forum.

[GetSeriousOK]

Nice work. Ride that white horse and wave that sword.

let me guess, ETRF (eTrade) is next to suffer your wrath? It's third on the L2 list here behind CFGN and GTSM:

https://www.otcmarkets.com/stock/GTHP/quote

And just how, exactly, are they manipulating GTHP? We are all ears. What did you tell FINRA?

[GetSeriousOK]

Nice work. Keep up the crusade.

[Zeppo]

Take it with the proverbial grain of salt. These tactics happen all the time in pennydom.

[splintered sunlight]

I would love to read about this.

Do you have a link?

Thanks

[myjog]

A complaint against CFGN (MPID),
CELADON FINANCIAL GROUP LLC
has been filed with SEC/FINRA for manipulating GTHP stock price.

[myjog]

Empty words pumpers who don’t have any money to put where their filthy mouth is, keep on puking bs on this forum.
Can understand that for some it takes a repeat to understand plain vanilla English because of their low IQ. So here’s repeat. The challenge is still on, if you think this stock has a potential to go up then where are your buys??!!
If you can’t add value then better shut up.

[GetSeriousOK]

You're forgetting to switch back and forth between your two aliases when you stage a fake conversation with yourself.

You know, like post #15235

[myjog]

Blah-blah-blah-blah-blah
Lots of “empty words” pumpers always puke bs on this forum. The challenge is still open for them, if you think that this company has potential then you should put your money where your filthy mouth is. How many shares you are buying? Do you have any money?
Unless market sees your buys, all you say is nothing but bs.
Why don’t you stop bs’ing & start buying? Where are your buys?
As per the latest Form-4, 1 of the directors bought stock recently.
So stop bs’ing & start buying!

[splintered sunlight]

Gotcha

Thanks

[GetSeriousOK]

one way: THAT person filed the complaint.

Which is possible and even probable. But it certainly doesn't mean the SEC will act on the complaint.

I'm not sure why someone would bash for years with two aliases (one with the g at the end, one without the g) and then file a complaint against a manipulator who brought the PPS down, but I'm not a psychologist.

[splintered sunlight]

TY

If you can't read about an SEC complaint unless the SEC files a case against the manipulator, then how do they know it was filed in the first place, LOL?

[GetSeriousOK]

I don't think you can read about an SEC complaint unless the SEC files a case against the manipulator.

Something to watch for, I guess, but it might also be BS, considering the source. Remember, this is the guy who insisted the company didn't really have Officers other than the CEO, and the CEO was pocketing the money instead of using it to fund the clinical trials.

In a thinly traded ticker, MM's can do some sketchy things without breaking the law. They can legally dip down and take out stop losses, for example.

GTHP's catalysts are still in the distance. GTHP will be susceptible to manipulation for several more months, unless the Chinese Play (SMI) comes true, which, as I have stated many times, is probably just BS from SMI. The first phase of determining whether SMI is still blowing smoke will be the appearance of money on the books when/if SMI submits the application to the NMPA. They are SUPPOSED to order $2.1M worth of product upon that submission.

SMI has informed the Company that it expects to complete the clinical trial required to obtain NMPA approval by the middle of this year. Further, SMI expects to receive final regulatory approval to market in China by the end of this year. Under the Agreement, approximately $2.1 million of the purchase orders must be fulfilled by the time SMI files its application with clinical data to the NMPA. Approximately $570,000 is due at the time NMPA approval is obtained, and another $1.24 million is due by March 31, 2024.

We all know that it's unrealistic for SMI to promise that they will finish the trials by mid year and achieve approval by the end of the year. I don't blame GTHP for SMI's failures to achieve anything they promise because it's been such obvious BS. I don't expect SMI to fork over $2.1 million this year or EVER, but who knows, stranger things have happened.

[GetSeriousOK]

how do YOU know THAT?

[splintered sunlight]

Would love to read about it - where can I find the information?

Thanks

[myjog]

A complaint against GTSM (MPID) broker-dealer / market-maker for manipulating GTHP stock price has been filed at FINRA/SEC.

[myjog]

Yes. It appears that sellers are back. However it also proves that “empty word” pumpers are no where to be found. There are absolutely no buyers for this stock. There are only sellers. So bottom line don’t believe in what “empty word” pumpers say. They never put their money where their mouth is.

[splintered sunlight]

A seller is back.

[myjog]

Not so fast. Loooooong way to go. As I stated multiple times before that for this stock bid is not at all increasing. Bid is stubbornly sitting below 0.20$. Unless bid goes up & uptick in bid is not taken. This stock has an uphill battle. Bears are all over this stock & there are no real buyers for this stock. There are only “empty word” pumpers.

[moneydreamer]

Nice volume today can’t wait for my next paycheck to add more$$$

[myjog]

10-Q is out.
Did anyone read it?

[myjog]

On what basis you think that this should be above 0.60$?
&
If you really think that this should be above 0.60$ then you should buy right now. Because from your perspective since it’s at 0.30$ so it’s currently way undervalued. Right?
How many you are buying?

[moneydreamer]

Have no idea what happened here, this one should be above .60 cents maybe people gave up good luck$$$